SCHEMBL12561990

SCHEMBL12561990

N#Cc1cc2c3c(ccc4c5c(Br)cc6c7c(ccc(c1c34)c75)C(=O)NC6=O)C(=O)NC2=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.36
GSK3B P49841 1/20 0.34
CHEK1 O14757 5/20 0.33
WEE1 P30291 2/20 0.33
PPOX P50336 1/20 0.33
PARP1 P09874 2/20 0.32
MEN1 O00255 1/20 0.32
RGS12 O14924 1/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32
CYP2C9 P11712 1/20 0.32
APEX1 P27695 1/20 0.32
CASP1 P29466 1/20 0.32
BRCA1 P38398 1/20 0.32
MTOR P42345 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13606485 0.96 NPSR1 (0.35) NPSR1GSK3BCHEK1WEE1PPOX
SCHEMBL13606484 0.92 NPSR1 (0.36) NPSR1GSK3BCHEK1WEE1PPOX
SCHEMBL1263254 0.91 PPOX (0.38) NPSR1GSK3BCHEK1WEE1PPOX
SCHEMBL15575338 0.88 PPOX (0.36) NPSR1CHEK1WEE1PPOXPARP1
SCHEMBL146244 0.87 NPSR1 (0.45) NPSR1GSK3BCHEK1WEE1PPOX
SCHEMBL13606637 0.85 NPSR1 (0.41) NPSR1CHEK1WEE1PARP1MEN1
SCHEMBL13606489 0.85 NPSR1 (0.41) NPSR1CHEK1PARP1MEN1RGS12
SCHEMBL13606631 0.84 NPSR1 (0.42) NPSR1GSK3BCHEK1WEE1PARP1
SCHEMBL17243112 0.84 NPSR1 (0.42) NPSR1GSK3BCHEK1WEE1PPOX
SCHEMBL13923619 0.84 CHEK1 (0.38) NPSR1GSK3BCHEK1WEE1PPOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2313409-B1 SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF BASF SE (DE) 2014-11-26 EP disclosed
US-8569501-B2 Semiconductor materials and methods of preparation and use thereof BASF SE (DE) 2013-10-29 US disclosed
US-20110136333-A1 SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF BASF SE (DE) 2011-06-09 US disclosed
WO-2009144205-A1 RYLENE-BASED SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF BASF SE (DE) 2009-12-03 WO disclosed
WO-2009144302-A1 SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF BASF SE (DE) 2009-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136333-A1 SEMICONDUCTOR MATERIALS AND METHODS OF PREPARATION AND USE THEREOF NIPSNAP1, SLC43A1, NCL NPSR1 2320/4885GSK3B 2606/4885CHEK1 1620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.